Amicus Therapeutics is a public American biopharmaceutical company. Amicus Therapeutics is located in Cranbury, New Jersey. Amicus Therapeutics is a company that focuses on cures for rare conditions and diseases. Amicus Therapeutics is known for their use of Chaperone Advanced Replacement Therapy. Know more on gcreport.com about Amicus Therapeutics.
Amicus Therapeutics has a great leadership team. Donald Hayden is the director of the company. He is very educated. In fact, Hayden has earned M.B.A. from Indiana University along with a B.A. from Harvard University. In addition to his success with education, Hayden also has had a great career. Before starting with Amicus Therapeutics , Hayden has had several executive positions.
Amicus Therapeutics is a very trustworthy company. They have received many grants from several affiliations, including the The Michael J. Fox Foundation and the Alzheimer’s Drug Discovery Foundation. In addition, since opening their office in New Jersey, the company also has expanded to San Diego, California. Read more at seeking.com about Amicus Therapeutics.
Amicus Therapeutics is very passionate about the work that they do. The company has developed a great program for Pompe disease that they are very proud of. This is big for the pharmaceutical industry. If you aren’t aware, Pompe disease is caused by an accumulation of glycogen in the lysosome due to deficiency of the lysosomal acid alpha-glucosidase enzyme.This disease is very rare but it is a condition that does require treatment. Amicus Therapeutics have also developed a treatment for individuals with Fabry disease. Their lead product for this disease happens to be migalastat. Fabry is also a rare genetic disease a deficiency of the enzyme alpha-galactosidase A that causes build up. Amicus Therapeutics certainty has a lot to be proud of. With their passion and hard work, this company will continue to grow in the pharmaceutical industry!